AHR and cancer: It has been demonstrated that the AhR lead agonistic acrylonitrile (Z)-2-(3,4-dichlorophenyl)-3-(1H-pyrrol-2-yl)prop-2-enenitrile (ANI-7) and analogs inhibit proliferation of a broad panel of breast [28], ovarian and lung [29] cancer cells.